Duration of Action of Remeron (Mirtazapine)
Remeron (mirtazapine) has an elimination half-life of approximately 20 to 40 hours, with steady-state plasma levels achieved within 5 days of regular dosing, making it suitable for once-daily administration. 1
Pharmacokinetic Profile
The duration of action is directly related to mirtazapine's pharmacokinetic properties:
- Peak plasma concentrations are reached within approximately 2 hours after oral administration 1
- Elimination half-life ranges from 20 to 40 hours across different patient populations 1
- Steady-state is attained within 5 days, with approximately 50% drug accumulation (accumulation ratio = 1.5) 1
- Bioavailability is approximately 50% due to first-pass metabolism 1
Important Clinical Considerations
Gender and Age Variations
The elimination half-life shows enantioselective pharmacokinetics with clinically significant differences:
- Females exhibit significantly longer elimination half-lives than males (mean 37 hours vs. 26 hours) 1
- Elderly patients demonstrate reduced oral clearance: 40% lower in elderly males and 10% lower in elderly females compared to younger adults 1
Special Populations Requiring Dose Adjustments
Renal impairment significantly affects duration of action:
- Moderate renal impairment (GFR 11-39 mL/min/1.73 m²): 30% reduction in clearance 1
- Severe renal impairment (GFR <10 mL/min/1.73 m²): 50% reduction in clearance 1
Hepatic impairment: 30% decrease in oral clearance 1
Obesity (BMI ≥28 kg/m²): 29.4% reduction in clearance 2
Drug Interactions Affecting Duration
Enzyme inducers substantially shorten duration of action:
- Carbamazepine: 60% decrease in plasma concentrations (2-fold increase in clearance) 1
- Phenytoin: 45% decrease in plasma concentrations (2-fold increase in clearance) 1
CYP inhibitors modestly prolong duration:
Clinical Implications
The 20-40 hour half-life supports once-daily dosing, typically administered at bedtime due to prominent sedative effects from H1 receptor antagonism 1. The relatively long half-life provides continuous therapeutic coverage throughout the 24-hour dosing interval and reduces the risk of withdrawal symptoms if a dose is missed.
Mirtazapine demonstrated faster onset of action compared to SSRIs (fluoxetine, paroxetine, sertraline) in clinical trials, though this refers to therapeutic effect rather than pharmacokinetic duration 3.